##semicolon##
холестерин, витамин D2, витамин D3, атероматоз пилакчалар, мия инсулти, миокард инфаркт, аорта, фибролипоматоз, фиброматоз, атерокальциноз.##submission.citations##
1. Anichkov, N.N. (2001). The combined theory of atherosclerosis pathogenesis and the role of lipid metabolism. Pathology International, 51(8), 591-597.
2. Brandenburg, V.M., Kramann, R., Koos, R. et al. (2010). Vitamin D – binding protein and arterial calcification in CKD: a prospective cohort study. J. Bone Miner. Res., 25(4), 921-932.
3. Brown, M.S., & Goldstein, J.L. (1986). A receptor-mediated pathway for cholesterol homeostasis. Science, 232(4746), 34-47.
4. Burlutskaya, A.V., & Tril, V.E. (2021). Epidemiological, clinical and morphological studies on early atherogenesis in fetuses and infants. Journal of Russian Cardiology, 26(S1), 42-48.
5. Chaulin, A.M., et al. (2020). Experimental models of atherosclerosis in rabbits: high-cholesterol diet protocols and genetic modifications. Cardiology Journal, 27(6), 765-772.
6. Davies, P. F. (2009). Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nature Clinical Practice Cardiovascular Medicine, 6(1), 16-26.
7. Demer, L.L., & Tintut, Y. (2008). Vascular calcification: pathobiology of a multifaceted disease. Circulation, 117(22), 2938-2948.
8. Gushchin, A.Ya., et al. (2017). Experimental approaches to evaluating atherosclerotic lesions and atherosclerosis progression in animal models. Biomedical Research, 28(14), 4412-4418.
9. Holick, M.F. (2007). Vitamin D deficiency. New Engl. J. Med., 357(3), 266-281.
10. Libby, P., Ridker, P.M., & Hansson, G.K. (2009). Inflammation in atherosclerosis: from pathophysiology to practice. J. Amer. Coll. Cardiol., 54(23), 2129-2138.
11. Lusis, A.J. (2000). Atherosclerosis. Nature, 407(6801), 233-241.
12. Ross, R. (1999). Atherosclerosis – an inflammatory disease. New Engl. J. Med., 340(2), 115-126.
13. Shanahan, C.M., Cary, N.R., Metcalfe, J.C., & Weissberg, P.L. (1999). High expression of genes for calcification-regulating proteins in human atherosclerotic plaques: evidence for skeletal regulation in vascular tissue. Circulation, 100(21), 2168-2176.
14. Shatnenabe, Y., et al. (1990). Genetic hyperlipidemic rabbit model and atherosclerosis progression. Atherosclerosis, 84(1), 85-93.
15. Stary, H.C., Chandler, A.B., Dinsmore, R.E. et al. (1995). A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. Circulation, 92(5), 1355-1374.
16. Tall, A.R., & Yvan-Charvet, L. (2015). Cholesterol, inflammation and innate immunity. Nat. Rev. Immunol., 15(2), 104-116.
17. Towler, D.A. (2008). Molecular and cellular regulators of vascular calcification. Prog. Cardiovasc. Dis., 50(4), 265-273.
18. Virmani, R., Kolodgie, F.D., Burke, A.P. et al. (2005). Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a progression marker. Circulation, 111(13), 1558-1566.
19. Watanabe, Y. (1980). Development of heritable hyperlipidemic rabbit strain (WHHL). Arteriosclerosis, 1(4).
20. Watanabe, Y. (1980). Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). Atherosclerosis, 36(2), 261-268.
21. Yang, F., Liu, L., & Li, M. (2013). Atherosclerotic disease in extracranial and intracranial carotid arteries and its role in ischemic cerebrovascular events. Journal of Stroke and Cerebrovascular Diseases, 22(8), 1234-1240.
22. Zhang, Q., Shang, A., & Zhang, S. (2017). Multifocal atherosclerotic disease prevalence in stroke patients. Neurology Research International, 2017, 8934521.